Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

← Back to our analysis

Original News Release

Organigram launches Shred Shotz

Mr. Eric Williams reports ORGANIGRAM GLOBAL EXPANDS FAST INNOVATION PLATFORM WITH SHRED SHOTZ, LEVERAGING SHRED BRAND EQUITY Organigram Global Inc. has launched Shred Shotz, a compact, single-serve 65-millilitre cannabis beverage powered by FAST, Organigram's fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset. This launch reflects Organigram's focus on differentiated innovation while leveraging the scale of Shred, one of the company's best-known brands. Shred surpassed $200-million in retail sales in 2025, underscoring the brand's momentum and record of expansion into new formats. With Shred Shotz, Organigram is introducing a compact format designed to help broaden the beverage category and bring new consumers into the segment. "Shred Shotz is another clear example of how we successfully translate consumer insights into meaningful product innovation," said Eric Williams, Organigram Global's vice-president of marketing. "With FAST powering the formulation, we are bringing that technology into a compact, single-serve beverage under the Shred brand, allowing us to expand into new occasions with a format built for taste, convenience and predictability." About FAST nanoemulsion technology FAST is a patent-pending nanoemulsion technology platform designed to support a faster-onset ingestible experience and consistent performance across product formats. Organigram has previously reported clinical pharmacokinetic (PK) research completed through the product development collaboration, a joint research and development initiative with BAT, showing that, depending on the ingestible format, FAST delivered up to approximately 50-per-cent faster onset, improved bioavailability (the amount absorbed into the bloodstream), and up to double cannabinoid delivery at peak compared with traditional ingestible products. Shred Shotz are expected to be available for sale at Canadian cannabis retailers sometime in March in Ontario and Atlantic Canada, with availability in other provinces expected to follow soon after. Each compact 65-millilitre bottle contains 10-milligram THC and will be available in Blue Razzberry and OG Lemonade flavours. About Organigram Global Inc. Organigram Global is a Nasdaq Global Select Market and Toronto Stock Exchange-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. Through its acquisition of Collective Project, Organigram Global participates in the United States and Canadian cannabinoid beverage markets. Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business relationships to extend the company's global footprint. Organigram has developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, Shred, Shred'ems, Monjour, Tremblant Cannabis, Collective Project, Trailblazer, Boxhot and Debunk. Organigram operates cultivation and processing facilities in Moncton, N.B., and Lac Superieur, Que., with a dedicated edibles manufacturing facility in Winnipeg, Man. The company operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 (carbon dioxide) and hydrocarbon extraction capabilities, and is optimized for formulation refinement, postprocessing of minor cannabinoids and preroll production. The facility in London is optimized for labelling, packaging and national fulfilment. The company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada). We seek Safe Harbor.
View at source ↗